Top

Journal of Experimental & Clinical Cancer Research

Published in:

Open Access 01-12-2017 | Erratum

Erratum to: Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers

Authors: Junjie Chen, Shenmeng Gao, Chunjing Wang, Zhonggai Wang, Huxiang Zhang, Kate Huang, Bin Zhou, Haiying Li, Zhijie Yu, Jianbo Wu, Chengshui Chen

Published in: Journal of Experimental & Clinical Cancer Research | Issue 1/2017

Excerpt

During production, Chengshui Chen was omitted from the list of corresponding authors in the original article [1]. Both Jianbo Wu and Chengshui Chen are corresponding authors for this article. …

Chen C, et al. Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers. J Exp Clin Cancer Res. 2016;35:173. doi:10.1186/s13046-016-0450-8.CrossRefPubMedPubMedCentral

Title: Erratum to: Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers
Authors: Junjie Chen
Shenmeng Gao
Chunjing Wang
Zhonggai Wang
Huxiang Zhang
Kate Huang
Bin Zhou
Haiying Li
Zhijie Yu
Jianbo Wu
Chengshui Chen
Publication date: 01-12-2017
Publisher: BioMed Central
Published in: Journal of Experimental & Clinical Cancer Research / Issue 1/2017
Electronic ISSN: 1756-9966
DOI: https://doi.org/10.1186/s13046-017-0501-9

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2017

Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma

The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells

CIP2A mediates fibronectin-induced bladder cancer cell proliferation by stabilizing β-catenin

RETRACTED ARTICLE: Up-regulation of CDK16 by multiple mechanisms in hepatocellular carcinoma promotes tumor progression

Drug repurposing for the treatment of glioblastoma multiforme

Heat shock factor 1 inhibits the mitochondrial apoptosis pathway by regulating second mitochondria-derived activator of caspase to promote pancreatic tumorigenesis

Keynote webinar | Spotlight on antibody–drug conjugates in cancer